INTERNATIONAL PATENT: HAV VACCINES LIMITED FILES APPLICATION FOR "TREATMENT OF CROHN'S DISEASE BY MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS AGENT"

GENEVA, March 2 -- HAV VACCINES LIMITED (Np-105 IcentreHoward WayNewport PagnellMilton Keynes MK16 9PY) filed a patent application (PCT/EP2025/073924) for "TREATMENT OF CROHN'S DISEASE BY MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS AGENT" on Aug 21, 2025. With publication no. WO/2026/041756, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAV VACCINES LIMITED (Np-105 IcentreHoward WayNewport PagnellMilton Keynes MK16 9PY)

Abstract: An immunotherapeutic agent against Mycobacterium avium subspecies paratuberculosis (MAP) f...